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Objectives The purpose of the study was to determine the effectiveness of a collaborative educational, continuous quality
improvement (CQI) initiative to increase appropriate use of coronary computed tomography angiography (CCTA).
Background Potential overuse of CCTA has prompted multisociety appropriate use criteria (AUC) publications.
Methods This prospective, observational study was conducted with pre-intervention (July 2007 to June 2008), intervention
(July 2008 to June 2010), and follow-up (July 2010 to December 2010) periods during which patients were en-
rolled in the Advanced Cardiovascular Imaging Consortium (ACIC) at 47 Michigan hospitals. Continuous educa-
tion was provided to referring physicians. The possibility of losing third-party payer coverage in the absence of a
measurable change in AUC was emphasized. AUC was compared between the 3 periods.
Results The study group included 25,387 patients. Compared with the pre-intervention period, there was a 23.4% in-
crease in appropriate (61.3% to 80%, p  0.0001), 60.3% decrease in inappropriate (14.6% to 5.8%,
p  0.0001), 40.8% decrease in uncertain (10.3% to 6.1%, p  0.0001), and 41.7% decrease in unclassifiable
(13.9% to 8.1%, p  0.0001) scans during follow-up. Between pre-intervention and follow-up, change in CCTA
referrals by provider specialty were cardiology (appropriate: 60.4% to 79.5%; inappropriate: 13% to 5.2%;
p  0.0001), internal medicine/family practice (appropriate: 51.1% to 70.4%; inappropriate: 20.2% to 12.5%;
p  0.0001), emergency medicine (appropriate: 83.6% to 91.6%; inappropriate: 9.1% to 0.6%; p  0.0001),
and other (appropriate: 61.1% to 83.2%; inappropriate: 18.6% to 5.9%; p  0.0001).
Conclusions Application of a systematic CQI and emphasis on possible loss of coverage were associated with a significant
improvement in the proportion of CCTA examinations meeting AUC across referring physician specialties.
(J Am Coll Cardiol 2012;60:1185–91) © 2012 by the American College of Cardiology Foundation
Published by Elsevier Inc. http://dx.doi.org/10.1016/j.jacc.2012.06.008Coronary artery disease (CAD) results in more than half of
cardiovascular deaths in the United States and remains
the leading cause of morbidity worldwide (1). Potential
consequences of incorrect diagnosis, including adverse
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tions have issued appropriate
use criteria (AUC).
Rapid advances in coronary
computed tomography angiogra-
phy (CCTA) make it possible to
image the coronary vasculature
with excellent accuracy for defin-
ing the presence and severity of
luminal stenoses, especially in
low- to intermediate-risk indi-
viduals (2). Widespread intro-
duction of 64-detector computed
tomography scanners has ad-
vanced noninvasive coronary im-
aging and led to great enthusi-
asm for the clinical adoption of
CCTA. This is now the fastest
growing application of computed tomography scanners in
the United States; approximately 500,000 Americans
undergo CCTA each year, stimulating professional and
public concern about appropriateness of its widespread
use (3).
The purpose of this study was to evaluate the effectiveness
f a collaborative continuous quality improvement (CQI)
nitiative on improving compliance with multisociety AUC
or CCTA and whether such improvement could be dem-
nstrated across all referring physician specialties.
Figure 1 Classification of CCTA Scans Into the 2010 AUC Tabl
For example, a low-risk symptomatic patient would be considered under Table 1; w
the patient would be further classified. In this example, continued symptoms desp
and inappropriate in the absence of symptoms and/or low-risk findings (Indication
Abbreviations
and Acronyms
ACIC  Advanced
Cardiovascular Imaging
Consortium
AUC  appropriate use
criteria
BCBS/BCNM  Blue Cross
Blue Shield/Blue Care
Network of Michigan
CAD  coronary artery
disease
CCTA  coronary
computed tomography
angiography
CQI  continuous quality
improvementMethods
Study population. The Advanced Cardiovascular Imaging
Consortium (ACIC) is a statewide CQI initiative sponsored
by Blue Cross Blue Shield/Blue Care Network of Michigan
(BCBS/BCNM) and includes 47 centers performing clini-
cal CCTA (4). It is approved by institutional review boards at
participating centers, includes a waiver of consent, and is led by
a physician “Clinical Champion” (Online Appendix). Patients
undergoing CCTA at all participating centers during the study
period were included in this analysis. ACIC data include
demographics, risk factors, symptoms, results of prior testing,
and medical history, as previously described (4,5). To ensure
data accuracy, patients are interviewed at point-of-service for
symptoms and history. Scheduled site audits are performed by
the coordinating center for proper data collection on 2% to
10% of scans (depending on quarterly volume per site) and all
major adverse events (death, acute coronary syndromes, and
coronary revascularization). There is no set acceptable error
rate for a center to remain in the ACIC.
Classification of appropriateness. This prospective study
was conducted over 3.5 years (July 2007 to December 2010).
Existing 2006 AUC (6) were used to define appropriateness.
After data collection, the 2010 AUC (7) became available
and used for data analysis. Additional analysis was per-
formed using the 2006 criteria.
CCTA scans were classified into the 3 AUC categories
using an automated computer-generated algorithm (7) (Fig. 1).
prior stress test, he/she would be considered under Table 4. Within each table,
ormal stress test result would deem the scan to be appropriate (Indication 20)
AD  coronary artery disease; CCTA  computed tomography angiography.es
ith a
ite a n
21). C
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or specific clinical scenarios not included in the AUC were
adjudicated by a pre-identified team consisting of the
Program Director (K.C.) and biostatistician (J.B.). When
review of all available data did not result in grouping under
the 3 categories, these scans were considered “unclassifi-
able.” This process was repeated using the 2006 AUC (6).
The CQI Program
Pre-intervention period: July 2007 to June 2008. During
pre-intervention, sites received quarterly reports on their
enrollment data with no emphasis on AUC.
Intervention period: July 2008 to June 2010.
1. Study initiation: CQI was announced at the June 2008
quarterly meeting.
2. Site-specific plan: The primary CQI emphasis consisted
of site-specific interventions led by Clinical Champions.
3. Educational plan: A secondary emphasis was education;
conferences offering 3.75 continuing medical education
credits were held in May 2010 at 4 locations around the
state.
4. Site-specific activities: From February to June 2010,
Clinical Champions led site-specific education (e.g.,
hospital grand rounds) and sent letters to their referring
physician base about the AUC. Wording in the letters
Clinical Characteristics of Study GroupTable 1 Clinical Characteristics of Study Gr
Pre-Intervention
(n  5,993)
Age (yrs) 57 13
Male 3,229 (54%)
Prior CAD 1,371 (23%)
Smoking 875 (14.8%)
Family history of premature CAD 2,637 (44%)
Diabetes 889 (15%)
Hypertension 3,036 (51%)
Hyperlipidemia 3,416 (57%)
Peripheral vascular disease 186 (3.1%)
Chronic obstructive lung disease 270 (4.5%)
Framingham risk
Low 3,500 (58.4%)
Intermediate 2,020 (33.7%)
High 473 (7.9%)
Pre-test likelihood of CAD
Low 1,726 (28.8%)
Intermediate 3,602 (60.1%)
High 665 (11.1%)
Stenosis on CCTA
0 (normal coronary arteries) 2,403 (40.1%)
50% 2,014 (33.6%)
50% 1,576 (26.3%)
Referral status
Inpatient 725 (12.1%)
Emergency department 1,193 (19.9%)
Outpatient 4,075 (68.0%)Values are mean  SD or n (%). The p value comparing pre-intervention wit
CAD  coronary artery disease; CCTA  coronary computed tomography aincluded imaging overuse and the possibility of losing
coverage entirely by BCBSM/BCN in the absence of a
definite, measurable change in appropriate use. All sites
were mandated to participate in the CQI. Of all sites, 19
(40.4%) initiated prospective evaluation of indications
with real-time feedback to referring physicians. Report-
ing of these activities was mandated by the CQI and by
BCBSM/BCN for continued participation. No financial
incentives were provided.
5. Data monitoring: Sites received feedback on their AUC
adherence, site-specific trends, and comparison with
ACIC as a whole. Clinical Champions were contacted
when no changes were noted over two quarters; when
deficient, meetings were set up among BCBSM/BCN
representatives, Clinical Champions, hospital adminis-
trators, and ACIC staff to evaluate continued participa-
tion. No site was dropped for lack of CQI participation.
Follow-up period: July to December 2010. Quarterly
comparative data were provided to sites; no active interven-
tions were undertaken.
Statistical analysis. Categoric variables were examined us-
ing Pearson’s chi-square or Fisher exact tests and are
reported as counts and % frequencies. Continuous variables
were examined using nonparametric Kruskal-Wallis tests or
analysis of variance depending on the distribution of the
Intervention
(n  15,396)
Follow-Up
(n  3,302) p Value
58 13 57 14 0.20
8,152 (53%) 1,796 (54%) 0.76
3,460 (22%) 679 (21%) 0.010
2,260 (14.7%) 511 (15.5%) 0.029
5,850 (38%) 1,288 (39%) 0.0001
2,549 (17%) 545 (17%) 0.042
8,407 (55%) 1,876 (57%) 0.0001
9,238 (60%) 2,047 (62%) 0.0001
539 (3.5%) 142 (4.3%) 0.0022
1,078 (7.0%) 334 (10.1%) 0.0001
0.0001
8,345 (54.2%) 1,737 (52.6%)
5,496 (35.7%) 1,182 (35.8%)
1,555 (10.1%) 383 (11.6%)
0.0001
4,157 (27%) 842 (25.5%)
9,730 (63.2%) 2,236 (67.7%)
1,509 (9.8%) 221 (6.7%)
0.041
6,513 (42.3%) 1,407 (42.6%)
4,819 (31.3%) 1,030 (31.2%)
4,049 (26.3%) 865 (26.2%)
0.0003
1,463 (9.5%) 433 (13.1%)
2,526 (16.4%) 546 (16.5%)
11,408 (74.1%) 2,325 (70.4%)ouph follow-up periods.
ngiography.
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Appropriate Use of Coronary CT Angiography September 25, 2012:1185–91data and are reported as mean  SD or medians where
appropriate. When considering the changes between pre-
intervention and follow-up periods, specific 1 degree of
freedom comparisons were made. A p  0.05 was consid-
ered significant. All tests were 2-sided.
Results
Clinical characteristics of study group. The study group
consisted of 25,387 patients (Table 1). Compared with
pre-intervention, patients in follow-up had higher coronary
risk factors but normal coronary arteries.
Indications for CCTA and AUC adjudication. Among
appropriate scans (n  18,266), the most common indica-
ions were detection of CAD in symptomatic low- to
ntermediate-risk patients (10,925 cases, 30.4%) and in the
etting of prior tests (5,342 cases, 29.2%) (Table 2). Among
nappropriate scans (n  2,198), the most common indica-
ion was the detection of CAD in asymptomatic individuals
1,510 cases, 68.7%), whereas the most common uncertain
ndication was detection of CAD in symptomatic low-risk
atients (1,654 of 1,978 cases, 83.6%).
rimary outcome: appropriate CCTA. PRE-INTERVENTION
VERSUS FOLLOW-UP. Appropriate use increased (3,672 of
5,993 [61.3%] to 2,642 of 3,302 [80.0%], p  0.0001),
inappropriate use decreased (873 of 5,993 [14.6%] to 192 of
3,302 [5.8%], p  0.0001), uncertain scans decreased (618
of 5,993 [10.3%] to 202 of 3,302 [6.1%], p  0.0001), and
unclassifiable scans decreased (830 of 5,993 [13.9%] to 266
of 3,302 [8.1%], p  0.0001) (Table 3).
Among inappropriate indications, there was a decrease of
CCTA use in low-risk asymptomatic individuals (596 of
820 [72.7%] to 99 of 173 [57.5%], p  0.0001) and
high-risk patients with acute symptoms (137 of 820 [16.7%]
to 22 of 173 [13%], p  0.0001). There was an increase in
asymptomatic patients for evaluation of graft patency (68 of
820 [8.3%] to 42 of 173 [24%], p  0.0001) and with prior
positive calcium scores (19 of 820 [2.3%] to 10 of 173
[5.5%], p  0.0001).
INTERVENTION VERSUS FOLLOW-UP. Appropriate use in-
creased (1,1601 of 15,396 [75.4%] to 2,642 of 3,302 [80%],
p  0.0001), inappropriate use decreased (1,305 of 15,396
8.5%] to 192 of 3,302 [5.8%], p 0.0001), uncertain scans
ecreased (1,225 of 15,396 [8.0%] to 202 of 3,302 [6.1%],
 0.0001), and unclassifiable scans decreased (1,265 of
5,396 [8.2%] to 266 of 3,302 [8.1%], p  0.0001).
econdary outcome: Appropriate referrals by specialty.
eferring physician specialties were available for 24,437
atients (96.3%). Significant changes were noted among all
hysician specialties between pre-intervention and follow-up (all
 0.0001) (Table 4).
omparison of 2006 and 2010 AUC. According to 2006
UC, 5,053 (19.9%) of scans during the study period were
ppropriate, 5,255 (20.7%) were inappropriate, and 2,545
10%) were uncertain. Approximately one half (N 12,534,
9.4%) were unclassifiable because the 2006 AUC: Cl
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September 25, 2012:1185–91 Appropriate Use of Coronary CT Angiography1) required more data for classification (e.g., electrocardio-
gram results and/or patient’s ability to exercise); or 2) did
not include specific indications (e.g., low-risk patients with
acute chest pain and normal electrocardiogram and/or
biomarkers).
When comparing 2006 (6) with 2010 (7) AUC, 9,953
(39.2%) CCTA scans remained in the same categories and
15,434 (60.8%) were reclassified (Fig. 2A). The greatest
change was noted among the 9,240 “unclassifiable” scans:
The 2010 AUC reclassified 8,916 (96.5%) as “appropriate,”
40 (0.4%) as “inappropriate,” and 284 (3.1%) as “uncertain.”
Of note, analysis using 2006 AUC demonstrated an
increase in appropriate (18% to 23%, p  0.0001) and a
decrease in inappropriate scans (28.4% to 13.8%, p 
0.0001) during the follow-up period compared with pre-
intervention (Fig. 2B).
Concordance between physician- and patient-reported
indications. Concordance between physician- and patient-
reported indications was studied; data were available for
24,691 patients (97.3%). During pre-intervention, there was
79% concordance, increasing to 82.8% during intervention
and 85.3% during follow-up (p  0.0001).
Discussion
This study demonstrates that a CQI incorporating educa-
tion and systematic peer-group feedback in a “real-world”
setting across a variety of institutions and physician special-
ties is associated with more appropriate CCTA use.
In addition to defining the presence or absence of CAD,
CCTA is cost-effective, provides diagnostic rapidity, and
has excellent prognostic value in selected patients (8). Such
characteristics combined with improved ease of interpreta-
tion have spurred widespread use and increased the potential
for inappropriate use. This concern was confirmed by the
fact that during the pre-intervention period, 14.6% of scans
were inappropriate. However, reduction of inappropriate
use to only 5.8% during follow-up is encouraging. There
was a slight (5.9%) increase in the percentage of patients
with normal coronary arteries during follow-up. The
strength of CCTA lies in its high sensitivity and negative
predictive value, that is, to rule out CAD. Thus, although
slight, the increase in normal coronary arteries is indirect
evidence of a corresponding increase in the appropriate
Primary Study Outcome:Change in AUC Acr ss Study PeriodTable 3 Primary Study Outcome:Change in AUC Across Study Period
Pre-Intervention
(n  5,993)
Intervention
(n  15,396)
Follow-Up
(n  3,302) p Value*
Appropriate 3,672 (61.3%) 11,601 (75.4%) 2,642 (80.0%) 0.0001
Inappropriate 873 (14.6%) 1,305 (8.5%) 192 (5.8%)
Uncertain 618 (10.3%) 1,225 (8.0%) 202 (6.1%)
Unclassifiable 830 (13.9%) 1,265 (8.2%) 266 (8.1%)
Values are n (%). *The p value comparing pre-intervention with follow-up and intervention with
follow-up periods.
AUC  appropriate use criteria.selection of patients. Changes in CCTA use were demon- Se T
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lu C
1190 Chinnaiyan et al. JACC Vol. 60, No. 13, 2012
Appropriate Use of Coronary CT Angiography September 25, 2012:1185–91strated with application of both 2006 and 2010 AUC.
Substantial changes to the AUC were evident by reclassifi-
cation of scans from 2006 to 2010; the 2006 AUC con-
tained 37 clinical situations, whereas the 2010 AUC con-
tained 93, demonstrating their inevitable evolution. The
significant increase in overall agreement between the
physician- and patient-reported indications by the end of
the study period also demonstrates that the change in
appropriateness was not a function of physicians “gaming
the system” by changing indications to “fit” the AUC.
These results differ from a physician education study by
Gibbons et al. (9) that demonstrated no significant change
in inappropriate single-photon emission computed tomog-
raphy at a single academic center. The absence of feedback
to referring physicians may have contributed to those
results, whereas rigorous feedback to Clinical Champions
and mandatory CQI participation were the key elements of
Figure 2 Reclassification of CCTA Scans From the 2006 to 20
The reclassification is demonstrated (A), and the results of the ACIC CQI using ththe present study. Moreover, single-photon emission com-puted tomography has been in clinical use longer than
CCTA with more “entrenched” referral patterns.
The ability of ACIC to affect quality metrics in “real-
world” CCTA use has been demonstrated by a substantial
radiation dose reduction by a similar CQI (5). These CQI
programs are unique in that they rely on peer-to-peer
feedback to encourage compliance with mutually agreed on
quality metrics, as opposed to third-party audits and nega-
tive reinforcement in achieving similar outcomes.
Study implications. One approach to moderating imaging
use is by mandatory “pre-authorization.” However, pre-
authorization processes are not often AUC derived. The
present study suggests that voluntary, mutually established
quality metrics reinforced by provider education and feed-
back can succeed in effectuating major changes, with impli-
cations extending beyond CCTA. Although the ACIC is a
complex undertaking requiring resource organization at
C
AUC are shown (B). AUC  appropriate use criteria.10 AU
e 2006every level of the process (referral, scheduling, point-of-care,
CA
m
n
a
w
g
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payers and physicians could result in similar successes on
larger scales.
Study limitations. The most important limitation of this
study is the lack of a control group, that is, centers not
participating in a CQI. Although it is speculated that a CQI
approach would be less burdensome than a pre-
authorization model, these approaches were not compared.
During the study period, numerous external events af-
fected CCTA use, including the deficit reduction act,
substantial concern regarding test overuse, evolution in
CCTA indications, and national recession. Although
changes observed in this study could reflect concerted effort,
these factors may have contributed to this trend. Moreover,
payment for CCTA by BCBSM is contingent on ACIC
participation. Although no threshold for appropriate testing
was announced, motivation for CQI participation might
have been at least partly driven by the appeal to continue to
remain in ACIC. This CQI began in 2008, before the 2010
AUC were released; the 2006 AUC were the basis of the
intervention. Because the 2010 AUC include more clinical
scenarios, all analyses were retrospectively based on these
criteria. Nevertheless, appropriate use of CCTA increased
and inappropriate use decreased using both the 2006 and
2010 criteria.
Modified Framingham risk score was calculated on the
basis of available clinical data. Data sampling for validation
of this score was beyond the scope of this study. Although
this method has been used in studies arising from large
databases, the validity of these estimates has not been tested.
Limitations of the AUC also must be considered. Indi-
cations may fit into multiple tables; for example, symptom-
atic, intermediate-risk patients without known CAD may
fit into both Tables 1 and 4 or symptomatic patients with
prior revascularization and stress testing may fit into both
Tables 4 and 6 (7).
onclusions
pplication of a systematic CQI program resulted in
arked improvement in the proportion of CCTA exami-
ations considered appropriate. This study presents an
lternative, nontraditional approach to use management
herein physicians and payers collaborate to address the
rowing problem of inappropriate imaging.Reprint requests and correspondence: Dr. Kavitha M. Chinnai-
yan, William Beaumont Hospital, 3601 West 13 Mile Road, Royal
Oak, Michigan 48073. E-mail: kchinnaiyan@beaumont.edu.
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APPENDIX
For a list of the ACIC participating sites and clinical champions,
please see the online version of this article.
